Constitutive activation of STAT3 and its other family members has been detected in a variety of human tumor specimens and cancer cell lines, including prostate cancer [6], so there is a need for time to develop novel, improved therapeutic approaches and new therapeutic agents to cure prostate cancer. The gene discussed is STAT3; the disease is prostate carcinoma.